Johnson & Johnson Vaccine Paused to Investigate Blood Clots

Iowa public health officials say they are temporarily stopping the use of the Johnson & Johnson coronavirus vaccine as federal health agencies investigate incidents of rare blood clots.

The Iowa Department of Public Health announced the pause Tuesday at the recommendation of the Centers for Disease Control and Prevention, which is reviewing data involving six reported U.S. cases of a severe type of blood clot in individuals after receiving the J&J vaccine.

Here in Delaware County, nearly six hundred residents have received the J&J vaccine. Brehme Drug in Manchester was the first to receive a shipment of doses in early March, with one hundred doses given at a special clinic on March 6th. The pharmacy then hosted three clinics this past weekend, including at the Manchester Legion, with nearly four hundred additional doses administered. Brehme Drug owner and pharmacist Ashley Brehme:

Meanwhile, Delaware County Public Health administered 90 doses of the J&J vaccine last week. Public Health Coordinator Charity Loecke:

Both Delaware County Public Health and Brehme Drug tell KMCH they have not heard of any local cases in which the J&J vaccine caused serious or life-threatening side effects. Typical side effects have included sore arm, redness around the injection area, body aches, chills and nausea.

Nearly seven million doses of the J&J vaccine have been given across the country since early March. Iowa was set to receive 1,800 doses of J&J vaccine this week. The state is still expecting to get more than 43,000 doses of Pfizer vaccine and nearly 32,000 doses of Moderna.

 

photo courtesy of Janelle Tucker/KMCH

ADVERTISEMENT